J. Seki

发表

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.

H. Fukui, T. Koike, T. Nakagawa, 2003, International journal of pharmaceutics.

A novel delivery system for amphotericin B with lipid nano-sphere (LNS).

H. Fukui, T. Koike, A. Saheki, 2003, International journal of pharmaceutics.

Decreased binding affinity of apolipoprotein C-II to Lipid Nano-Sphere (LNS) plays an important role in the plasma half-life and reduced hæmolytic activity

T. Mayumi, H. Fukui, A. Saheki, 2004 .

A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.

T. Mayumi, H. Sasaki, H. Fukui, 2004, International journal of pharmaceutics.

Plasma lipoproteins as drug carriers: Pharmacological activity and disposition of the complex of β-sitosteryl-β-D-glucopyranoside with plasma lipoproteins

M. Watanabe, M. Sugiyama, T. Nakagawa, 1985 .

Decreased binding affinity of apolipoprotein E plays an important role in the reduced hepatic clearance of Lipid Nano-Sphere (LNS)

T. Mayumi, H. Fukui, A. Saheki, 2004 .

[Analysis of cells in bronchoalveolar lavage and ultrastructure of lung tissues in experimental silicosis].

O. Kawanami, H. Yoneyama, J. Seki, 1993, Nihon Kyobu Shikkan Gakkai zasshi.

Influence of Preparation Method on Polynucleotide Conformation and Pharmacological Activity of Lipoplex Authors

I. Tamai, H. Fukui, Yuji Hoshi, 2010 .

Effect of back pressure on emulsification of lipid nanodispersions in a high-pressure homogenizer.

T. Nakanishi, I. Tamai, A. Saheki, 2012, International journal of pharmaceutics.

Title Influence of preparation method on polynucleotide conformation andpharmacological activity of lipoplex

H. Fukui, I. Tamai, Yuji Hoshi, 2017 .

Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).

H. Fukui, T. Koike, A. Saheki, 2003, International journal of pharmaceutics.

In Vitro and In Vivo Activities of NS-718, a New Lipid Nanosphere Incorporating Amphotericin B, againstAspergillus fumigatus

S. Kohno, K. Tomono, M. A. Hossain, 1999, Antimicrobial Agents and Chemotherapy.

Studies on the absorption of sodium guaiazulene-3-sulfonate. II. Absorption mechanism from nasal and intestinal membrane.

M. Sugiyama, J. Seki, H. Mukai, 1985, Journal of pharmacobio-dynamics.

Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins.

T. Mayumi, H. Fukui, T. Koike, 2004, International journal of pharmaceutics.

Lipid nano-sphere(LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV.

H. Sasaki, H. Fukui, M. Sugiyama, 1994 .

In vivo application of lipoproteins as drug carriers: pharmacological evaluation of sterylglucoside-lipoprotein complexes.

M. Sugiyama, J. Seki, 1991, Targeted diagnosis and therapy.

Influence of preparation method on polynucleotide conformation and pharmacological activity of lipoplex.

H. Fukui, I. Tamai, Yuji Hoshi, 2011, International journal of pharmaceutics.